Precision Medicine in Graves’ Disease: CD40 Gene Variants Predict Clinical Response to an Anti-CD40 Monoclonal Antibody

BACKGROUND: CD40, a key co-stimulatory molecule expressed on antigen-presenting cells, is genetically associated with a number of autoimmune diseases including Graves’ disease (GD). Therefore, recent therapies targeting CD40 have been developed, including the anti-CD40 monoclonal antibody Iscalimab....

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Endocrinol (Lausanne)
Glavni autori: Faustino, Larissa C., Kahaly, George J., Frommer, Lara, Concepcion, Erlinda, Stefan-Lifshitz, Mihaela, Tomer, Yaron
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Endocrinology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8212124/
https://ncbi.nlm.nih.gov/pubmed/34149627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.691781
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items